Pyxis Oncology Inc. (PYXS)
undefined
undefined%
At close: undefined
1.62
-0.55%
Pre-market Dec 16, 2024, 04:01 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -73.79M -120.72M -75.97M -12.83M -2.77M
Depreciation & Amortization 1.93M 709.00K 647.00K 469.00K -
Stock-Based Compensation 16.95M 15.76M 6.44M 44.00K 28.00K
Other Working Capital -8.16M 12.83M 2.03M 1.73M 213.00K
Other Non-Cash Items -4.13M 10.41M 20.60M -56.00K -264.00K
Deferred Income Tax - - 6.28M - -
Change in Working Capital -11.66M 4.50M 6.68M 2.29M 505.00K
Operating Cash Flow -70.71M -89.33M -35.33M -10.08M -2.24M
Capital Expenditures -6.73M -6.40M -540.00K -1.48M -
Acquisitions 6.66M - -50.00K - -
Purchase of Investments -196.83M - -50.00K - -
Sales Maturities Of Investments 92.05M - 50.05K - -
Other Investing Acitivies - - -50 - -
Investing Cash Flow -104.85M -6.40M -590.00K -1.48M -
Debt Repayment - - - - -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies -193.00K 183.00K 151.75M 32.00K 43.90M
Financial Cash Flow 5.93M 183.00K 304.04M 35.00K 21.95M
Net Cash Flow -169.63M -95.55M 268.13M -11.53M 19.72M
Free Cash Flow -77.44M -95.73M -35.87M -11.57M -2.24M